90
Participants
Start Date
March 13, 2017
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2027
Temozolomide
"oral temozolomide (75 mg/m2), given 7 days per week, for a maximum of 49 days during radiation therapy.~Starting 1 month after radiation therapy, additional temozolomide will be given as chemotherapy cycles. Each cycle is 28 days.~For the first cycle, temozolomide will be administered (150 mg/m2) once per day for 5 days.~If the subject tolerates the first cycle well, temozolomide will be prescribed at 200 mg/m2 for cycles 2 through 6. Each cycle is 28 days."
radiation therapy
Conformal radiation administered daily, M-F, to a total dose of 61.2 Gray in 34 fractions.
Ascorbic Acid
"Intravenous infusions of 87.5g of ascorbate administered three times weekly during radiation.~After radiation, ascorbate is administered twice weekly through the end of cycle 6 of temozolomide."
Holden Comprehensive Cancer Center, Iowa City
Lead Sponsor
Holden Comprehensive Cancer Center
OTHER
National Cancer Institute (NCI)
NIH
Gateway for Cancer Research
OTHER
Bryan Allen
OTHER